Results 241 to 250 of about 180,278 (321)

A hsp70-2 Mutation Recognized by CTL on a Human Renal Cell Carcinoma [PDF]

, 1999
Catherine Gaudin, Florence Kremer, Eric Angevin, Véronique Scott, Frédéric Triebel   +4 more
openalex   +1 more source

Engineering antibodies with cancer‐associated binding sites

BMEMat, EarlyView.
This review describes antibodies that perform direct/indirect roles in cancer treatment by binding to effective targets and discusses how antibodies kill tumors and modulate tumor microenvironment through these targets. The classification of expression systems for antibody production is summarized to guide appropriate selection based on different ...
Yinqi Tian, Yumeng Pan, Yingchun Zhang, Fangling Wang, Zejun Wang   +4 more
wiley   +1 more source

Structure-guided disulfide engineering restricts antibody conformation to elicit TNFR agonism. [PDF]

Nat Commun
Elliott IG, Fisher H, Chan HTC, Inzhelevskaya T, Mockridge CI, Penfold CA, Duriez PJ, Orr CM, Herniman J, Müller KTJ, Essex JW, Cragg MS, Tews I.   +12 more
europepmc   +1 more source

Dose Dependence of CTL Precursor Frequency Induced by a DNA Vaccine and Correlation with Protective Immunity Against Influenza Virus Challenge [PDF]

, 1999
Tong‐Ming Fu, Liming Guan, Arthur Friedman, Timothy Schofield, Jeffrey B. Ulmer, Margaret A. Liu, John Donnelly   +6 more
openalex   +1 more source

Designing next‐generation immune cell therapies with nanomaterials

BMEMat, EarlyView.
Nanomaterials are transforming immune cellular therapies (ICT) by addressing challenges like tumor accessibility and lengthy manufacturing. This perspective highlights innovations such as magnetic nanoparticles for target identification, lipid nanoparticles for T cell stimulation, and nanoparticle‐mediated gene cytokine delivery. These advances promise
Kangfu Chen, Wenhan Wang, Zongjie Wang
wiley   +1 more source

Mesenchymal stem cell exosomes therapy for the treatment of traumatic brain injury: mechanism, progress, challenges and prospects. [PDF]

J Transl Med
Liu MW, Li H, Xiong GF, Zhang BR, Zhang QJ, Gao SJ, Zhu YL, Zhang LM.   +7 more
europepmc   +1 more source

CTL responses induced by a single immunization with peptide encapsulated in biodegradable microparticles

, 1997
Charalambos D. Partidos, P. Vohra, David T. Jones, Graham H. Farrar, Michael Steward   +4 more
openalex   +1 more source

Partial Agonist Effect Influences the CTL Response to a Heterologous Dengue Virus Serotype [PDF]

, 1999
J Zivný, Matthew C. DeFronzo, William Jarry, Julie Jameson, John Cruz, Francis A. Ennis, Alan L. Rothman   +6 more
openalex   +1 more source

Immune checkpoint inhibitor therapy is associated with a decreased risk of developing melanoma brain metastases. [PDF]

BJC Rep
Fager A, Samuelsson M, Olofsson Bagge R, Pivodic A, Bjursten S, Levin M, Jespersen H, Ny L.   +7 more
europepmc   +1 more source

DNA vaccination primes MHC class I-restricted, simian virus 40 large tumor antigen-specific CTL in H-2d mice that reject syngeneic tumors. [PDF]

, 1996
Reinhold Schirmbeck, W Böhm, Jörg Reimann   +2 more
openalex   +1 more source